At ViiV Healthcare, we are committed to supporting innovative, forward-thinking community collaborations that break down isolation and stigma for women of color across the gender spectrum and strengthen organizations and initiatives that link women to networks of care.
We know that information, social relationships and emotional support can be transformational to women’s physical health and quality of life. That’s why we’re dedicated to ensuring that cis and trans women’s needs and voices are prioritized in research, policy, advocacy and community change efforts and that all women can connect with the resources and support they deserve.
Since 2017, Positive Action for Women (PAFW) has focused on breaking down stigma and isolation for cis and trans women of color living with HIV and the organizations that serve them. The PAFW initiative has invested $4.5M in community-led initiatives that forged in-person and online networks, created content by and for women of color living with HIV, fueled community-led research to close gaps in knowledge and reached more than 75,000 people.
Risk to Reasons 2022 funding cycle for organizations in the U.S. and Puerto Rico is currently open. The deadline to submit a proposal is June 27, 2022.
For more information, download the request for proposal here.
Click here to access the online grantee portal.
All questions and inquiries should be directed to the ViiV Healthcare Help Desk at email@example.com
The Positive Action for Women Story
In 2016, with the help of leaders and communities across the country, ViiV Healthcare spoke with women living with HIV and commissioned ethnographic research in New Orleans to learn more about the experiences of Black women and HIV networks of support and care. We reviewed literature and conducted an up-to-date epidemiology profile to better understand trends in time, geography and solutions for women of color living with HIV. Through this listening, it was clear that women of color living with HIV are heavily impacted by isolation at three levels:
- Isolation from their friends, family and peers as a result of fear and HIV stigma;
- Isolation among service providers and in local planning efforts, which often do not consider the needs of women living with HIV; and
- Isolation from the larger cultural discourse around HIV and women’s wellness, including in clinical research, media, culture and communications.
Today, Positive Action for Women represents ViiV Healthcare’s continued commitment to all women in the US, especially those disproportionately affected by HIV. We believe that addressing the health disparities faced by all women of color, particularly Black women,1 across the continuum of care is a key priority in closing the gap in HIV disparities in the US.
Research and Art, Breaking Down Isolation with Take My Hand
Based on the real stories of Black cis and trans women living with HIV, Take My Hand is ViiV Healthcare’s newest impact theatre piece and community activation that focuses exclusively on the urgency and hope around Black women and HIV. As part of ViiV’s Positive Action for Women initiative, the performance and discussions turn research into art, helping audiences feel more comfortable talking about HIV and how to connect women living with HIV to networks of support.
Sparking Innovation and Collaboration in the Field
ViiV Healthcare is pleased to spotlight the inspiring work of the Women’s Connection, a program of the AIDS Foundation of Chicago (AFC), AFC’s Women’s Connection embodies the core strategies of ViiV Healthcare’s Positive Action for Women initiative — to foster networks of women and organizations who focus on the impact of HIV on cis and trans women of color and help to engage women in care. In Chicago, the Women’s Connection engaged a network of women leaders, conducted a city-wide plan and convened a unique collaboration focused on the needs and experiences of Black cis and trans women living with HIV.
- Geter, et al. Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015. PLoS One 2018; 13(1) e0189973